According to the study, researchers analyzed electronic health records from nearly 40,000 adults with type 2 diabetes who started GLP-1 receptor agonists, SGLT-2 inhibitors, or DPP-4 inhibitors between 2019 and 2024
Since different addictions share overlapping brain circuitry, brenipatide may open treatment options for other substance use disorders, Moussawi thinks
This includes safe titration of dosages and ongoing medical oversight tailored to individual needs
Amazing Meds+2GoodRx+2
Glickman says that while you should expect to pay up to $1,400 monthly without insurance, there are cheaper options if youre on a budget: Assistance programs or manufacturer discounts may help reduce costs, and there are compounded options available at lower costs, he notes
The glucagon component is the part that neither Mounjaro nor Wegovy has